SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001333277-21-000024
Filing Date
2021-01-28
Accepted
2021-01-28 15:00:06
Documents
1
Period of Report
2021-01-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3742
  Complete submission text file 0001333277-21-000024.txt   5304
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 300 ELLIOTT AVE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
Loewy Caroline M (Reporting) CIK: 0001367451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 21564433